Current control of diabetes after cardiac rehabilitation program: the ReCardio registry

23 April 2026 (08:00 - 18:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Miss Manuela Sestayo Fernandez

Health Research Institute of Santiago de Compostela, Santiago de Compostela (Spain)

5 More presentations in this session

Presentation thumbnail

Risk factor outcomes following flexible delivery models in cardiac rehabilitation: rehabilitation in the real world

Ms J. Harris (Ottawa, CA)

Abstract Slides

Presentation thumbnail

Patient-centered wearable-integrated rehabilitation program for patients with heart failure: a multicenter randomized controlled trial

Doctor Y. Katsumata (Tokyo, JP)

Abstract Slides

Presentation thumbnail

Accuracy and prognostic value of calculated versus CPET-derived METs in phase II cardiac rehabilitation

Doctor I. Aguiar Ricardo (Lisbon, PT)

Abstract Slides

Presentation thumbnail

Clinical efficacy of a digital therapeutic for cardiac rehabilitation : a multicenter randomized controlled trial

Assistant Professor J. Song (Seoul, KR)

Abstract Slides

Presentation thumbnail

Changes in functional capacity after a contemporary cardiac rehabilitation program: results from the ReCardio national registry

Miss M. Sestayo Fernandez (Santiago de Compostela, ES)

Abstract Slides

Access the full session

Session thumbnail

Cardiac rehabilitation programmes: which components are effective?

The Event

Event poster

ESC Preventive Cardiology 2026

23 April - 25 April 2026

You may be interested in

Congress Presentation

Cardiovascular risk reduction: should we target pre-diabetes?

Congress Presentation

Case 1 - a middle-aged male with T2DM: polypharmacy in a primary prevention setting

Congress Presentation

Diabetes as a major comorbidity in heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources